CRDF
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Cardiff Oncology reported positive update from Phase 2 onvansertib trial in mCRCJan 27, 2026
- Cardiff Oncology announces positive data from ongoing randomized Phase 2 first-line RAS-mutated metastatic colorectal cancer trial (CRDF-004)Jul 30, 2025
- Cardiff Oncology announces positive data from trial of Onvansertib and paclitaxel in metastatic triple-negative breast cancer at ASCO 2025Jun 3, 2025